Home >> Life Sciences >> Pharmaceuticals >> General Pharmaceuticals

United States Antineoplastic Agents Market Report to 2021

Published: Nov-2016 | Format: PDF | QY Research | Number of pages: 105 | Code: MRS - 84285


Notes:
Sales, means the sales volume of Antineoplastic Agents
Revenue, means the sales value of Antineoplastic Agents

This report studies sales (consumption) of Antineoplastic Agents in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Novartis
Pfizer, Inc.
Roche
Sanofi
Merck & Co., Inc.
GlaxoSmithKline plc
Johnson & Johnson
AstraZeneca plc.
Eli Lilly and Company
Abbvie
AMGen
Teva Pharmaceutical Industries Ltd.
Bayer AG
Bristol-Myers Squibb
Astellas Pharma
Daiichi Sankyo

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Alkylating Agent
Anti-metabolic Tumor Drugs
Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
Others 
Split by applications, this report focuses on sales, market share and growth rate of Antineoplastic Agents in each application, can be divided into
First Level Hospital
Two Level Hospital
Three Level Hospital
Others 


Table of Contents

United States Antineoplastic Agents Market Report 2021
1 Antineoplastic Agents Overview
1.1 Product Overview and Scope of Antineoplastic Agents
1.2 Classification of Antineoplastic Agents
1.2.1 Alkylating Agent
1.2.2 Anti-metabolic Tumor Drugs
1.2.3 Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
1.2.4 Others 
1.3 Applications of Antineoplastic Agents
1.3.1 First Level Hospital
1.3.2 Two Level Hospital
1.3.3 Three Level Hospital
1.3.4 Others 
1.4 USA Market Size (Value and Volume) of Antineoplastic Agents (2011-2021)
1.4.1 USA Antineoplastic Agents Sales, Revenue and Price (2011-2021)
1.4.2 USA Antineoplastic Agents Sales and Growth Rate (2011-2021)
1.4.3 USA Antineoplastic Agents Revenue and Growth Rate (2011-2021)

2 USA Antineoplastic Agents Competition by Manufacturers
2.1 USA Antineoplastic Agents Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Antineoplastic Agents Revenue and Share by Manufactures (2015 and 2016)

3 USA Antineoplastic Agents (Volume and Value) by Type
3.1 USA Antineoplastic Agents Sales and Market Share by Type (2011-2021)
3.2 USA Antineoplastic Agents Revenue and Market Share by Type (2011-2021)

4 USA Antineoplastic Agents (Volume) by Application

5 USA Antineoplastic Agents Manufacturers Analysis
5.1 Novartis
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Antineoplastic Agents Product Type and Technology
5.1.2.1 Alkylating Agent
5.1.2.2 Anti-metabolic Tumor Drugs
5.1.3 Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)
5.2 Pfizer, Inc.
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Alkylating Agent
5.2.2.2 Anti-metabolic Tumor Drugs
5.2.3 Pharmaceuticals Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
5.3 Roche
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Roche Product Type and Technology
5.3.2.1 Alkylating Agent
5.3.2.2 Anti-metabolic Tumor Drugs
5.3.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)
5.4 Sanofi
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Eli Lilly and Company Product Type and Technology
5.4.2.1 Alkylating Agent
5.4.2.2 Anti-metabolic Tumor Drugs
5.4.3 Sanofi Sales, Revenue, Price of Sanofi (2015 and 2016)
5.5 Merck & Co., Inc.
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Merck & Co., Inc. Product Type and Technology
5.5.2.1 Alkylating Agent
5.5.2.2 Anti-metabolic Tumor Drugs
5.5.3 Merck & Co., Inc. Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
5.6 GlaxoSmithKline plc
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 GlaxoSmithKline plc Product Type and Technology
5.6.2.1 Alkylating Agent
5.6.2.2 Anti-metabolic Tumor Drugs
5.6.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
5.7 Johnson & Johnson
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Johnson & Johnson Product Type and Technology
5.7.2.1 Alkylating Agent
5.7.2.2 Anti-metabolic Tumor Drugs
5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.8 AstraZeneca plc.
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 AstraZeneca plc. Product Type and Technology
5.8.2.1 Alkylating Agent
5.8.2.2 Anti-metabolic Tumor Drugs
5.8.3 AstraZeneca plc. Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
5.9 Eli Lilly and Company
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 Eli Lilly and Company Product Type and Technology
5.9.2.1 Alkylating Agent
5.9.2.2 Anti-metabolic Tumor Drugs
5.9.3 Eli Lilly and Company Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
5.10 Abbvie
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Abbvie Product Type and Technology
5.10.2.1 Alkylating Agent
5.10.2.2 Anti-metabolic Tumor Drugs
5.10.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)
5.11 AMGen
5.12 Teva Pharmaceutical Industries Ltd.
5.13 Bayer AG
5.14 Bristol-Myers Squibb
5.15 Astellas Pharma
5.16 Daiichi Sankyo

6 Antineoplastic Agents Technology and Development Trend
6.1 Antineoplastic Agents Technology Analysis
6.2 Antineoplastic Agents Technology Development Trend

7 Research Findings and Conclusion


List of Tables and Figures 

Figure Picture of Antineoplastic Agents
Table Classification of Antineoplastic Agents
Figure USA Sales Market Share of Antineoplastic Agents by Type in 2015
Figure Alkylating Agent Picture
Figure Anti-metabolic Tumor Drugs Picture
Figure Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives Picture
Figure Others Picture
Table Applications of Antineoplastic Agents
Figure USA Sales Market Share of Antineoplastic Agents by Application in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Table USA Antineoplastic Agents Sales, Revenue and Price (2011-2021)
Figure USA Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure USA Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Table USA Antineoplastic Agents Sales of Key Manufacturers (2015 and 2016)
Table USA Antineoplastic Agents Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antineoplastic Agents Sales Share by Manufacturers
Figure 2016 Antineoplastic Agents Sales Share by Manufacturers
Table USA Antineoplastic Agents Revenue by Manufacturers (2015 and 2016)
Table USA Antineoplastic Agents Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Antineoplastic Agents Revenue Share by Manufacturers
Table 2016 USA Antineoplastic Agents Revenue Share by Manufacturers
Table USA Antineoplastic Agents Sales and Market Share by Type (2011-2021)
Table USA Antineoplastic Agents Sales Share by Type (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Type (2011-2021)
Figure USA Antineoplastic Agents Sales Growth Rate by Type (2011-2021)
Table USA Antineoplastic Agents Revenue and Market Share by Type (2011-2021)
Table USA Antineoplastic Agents Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Antineoplastic Agents by Type (2011-2021)
Figure USA Antineoplastic Agents Revenue Growth Rate by Type (2011-2021)
Table USA Antineoplastic Agents Sales and Market Share by Application (2011-2021)
Table USA Antineoplastic Agents Sales Share by Application (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Application (2011-2021)
Figure USA Antineoplastic Agents Sales Growth Rate by Application (2011-2021)
Table Novartis Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)
 

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

North America Pharmaceutical Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Sep-2017 | Global Info Research | Pages : 119 | Code : MRS-166762 | 4480

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications. Pharmaceutical companies may deal in generic or brand medications. Scope of the Report: This report focuses on the Pharmaceutical in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Novartis Read more

North America Pinaverium Bromide Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Sep-2017 | Global Info Research | Pages : 116 | Code : MRS-166761 | 4480

Pinaverium Bromide is a medicine available in a number of countries worldwide. Pinaverium Bromide is a drug used for functional gastrointestinal disorders. It belongs to a drug group call antispasmodic and acts as a calcium channel blocker in helping to restore the normal contraction process of the bowel. It is most effective when taken for a full course of treatment and is not designed for immediate symptom relief or sporadic, intermittent use. Scope of the Report: This report focuse Read more

North America Ophthalmology Amniotic Membrane Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Sep-2017 | Global Info Research | Pages : 116 | Code : MRS-166760 | 4480

Amniotic membrane (AM) can function in the eye as a basement membrane substitute or as a temporary graft. It has anti-inflammatory and anti-scarring effects and contains growth factors that promote epithelial wound healing on the surface of the eye. Scope of the Report: This report focuses on the Ophthalmology Amniotic Membrane in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and applica Read more

Asia-Pacific Docusate Sodium Market by Manufacturers, Regions, Type and Application, Forecast to 2022

Sep-2017 | Global Info Research | Pages : 120 | Code : MRS-166617 | 4480

Docusate sodium is a versatile and highly effective and efficient pharmaceutical grade surfactant. Docusate sodium is often used as an exicipient in pharmaceutical production processes where it acts as a solubilizing agent for poorly soluble API's as well as a dispersing and emulsifying agent. It is also used as active pharmaceutical ingredients (API) in the production of stool softeners and prenatal and geriatric iron preparations. Scope of the Report: This report focuses on the Docusa Read more

United States Neurofeedback System Market by Manufacturers, States, Type and Application, Forecast to 2022

Sep-2017 | Global Info Research | Pages : 115 | Code : MRS-166485 | 4480

Neurofeedback is a non-invasive method of direct brain function training. It is also a type of biofeedback and is therefore, also called EEG Biofeedback. It uses the electrodes (which act like tiny microphones) placed on the client's scalp to record and amplify the EEG, or brainwaves and control auditory, visual, and/or tactile feedback which allows learning to take place. This operant learning initiates self-regulation and enhances relaxation, both necessary components of good brain functi Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Sphygmomanometers Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 118 | Code : MRS-166484 | 4880

This report studies the Sphygmomanometers market. Sphygmomanometer, also called blood pressure meter, blood pressure monitor, or blood pressure gauge, is an instrument for measuring arterial blood pressure. Scope of the Report: This report focuses on the Sphygmomanometers in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segmen Read more

Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape

Aug-2017 | GBI Research | Pages : 0 | Code : MRS-166015 | 4995

Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV), which can lead to acute and chronic hepatitis infection. According to the World Health Organization (WHO), in 2015 there were 1.75 million new HCV infections globally, and approximately 399,000 people die each year from hepatitis C, mostly due to cirrhosis and hepatocellular carcinoma. The APAC region has diverse HCV epidemiology, with prevalence ranging from 0.1% to 4.7%, and a unique genotype (GT) distributi Read more

Global Smoking Cessation Products Market Research Report 2017

Sep-2017 | QY Research | Pages : 102 | Code : MRS-165986 | 2900

In this report, the global Smoking Cessation Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Smoking Cessation Products in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Read more

Global Salicylamide Market Research Report 2017

Sep-2017 | QY Research | Pages : 106 | Code : MRS-165978 | 2900

In this report, the global Salicylamide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Salicylamide in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Asia - India Global Salicyl Read more

Global Colloids (Blood Plasma) Market Research Report 2017

Sep-2017 | QY Research | Pages : 111 | Code : MRS-165972 | 2900

In this report, the global Colloids (Blood Plasma) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Colloids (Blood Plasma) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Asia - Read more

Single User | $(USD)3800 View Pricing